Genetic Technologies
GENE
#10486
Rank
โ‚ฌ3.18 M
Marketcap
0,66ย โ‚ฌ
Share price
0.00%
Change (1 day)
-71.49%
Change (1 year)

Genetic Technologies (GENE) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚ฌ0.5 Million

According to Genetic Technologies's latest financial reports the company's total debt is โ‚ฌ0.5 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Genetic Technologies - Total debt on balance sheet (from 2004 to 2024)

Total debt by year

Year Total debt Change
2024-06-30โ‚ฌ0.54 M68.85%
2023-06-30โ‚ฌ0.32 M-24.58%
2022-06-30โ‚ฌ0.42 M231.4%
2021-06-30โ‚ฌ0.12 M-56.12%
2020-06-30โ‚ฌ0.29 M
2019-06-30N/A
2015-06-30โ‚ฌ0.01 M-99%
2014-06-30โ‚ฌ1.72 M
2013-06-30N/A-100%
2012-06-30โ‚ฌ0.01 M-71.32%
2011-06-30โ‚ฌ0.05 M-80.55%
2010-06-30โ‚ฌ0.25 M20.89%
2009-06-30โ‚ฌ0.21 M17.36%
2008-06-30โ‚ฌ0.18 M-45.03%
2007-06-30โ‚ฌ0.33 M-66.55%
2006-06-30โ‚ฌ0.98 M-24.4%
2005-06-30โ‚ฌ1.3 M230.19%
2004-06-30โ‚ฌ0.39 M-2.85%
2003-06-30โ‚ฌ0.4 M
2002-06-30N/A-100%
2001-06-30โ‚ฌ0.07 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eterna Therapeutics
ERNA
โ‚ฌ0.47 M-5.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
โ‚ฌ0.18 B 36,143.27%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ5.60 B 1,114,666.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ5.48 B 1,089,417.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚ฌ2.53 M 402.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Danaher
DHR
โ‚ฌ14.47 B 2,877,509.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ30.64 B 6,091,090.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
โ‚ฌ0.68 B 135,198.52%๐Ÿ‡บ๐Ÿ‡ธ USA